Group 1 - Wuhan has become a hub for innovative medical technologies, producing world-class achievements such as the first visual intervention robot and the first Parkinson's autologous cell therapy drug [1][2] - The AI diagnostic system "Endoscope Spirit" developed by Wuhan Chujingling Medical Technology Co., Ltd. has gained international attention, covering 44 countries and serving over 1,000 hospitals [1] - Wuhan Yirui De Group's transcranial magnetic stimulation device for treating depression received the first Class III medical device registration certificate in the mental health field in China, holding over 400 domestic and international patents [1] Group 2 - In the Optical Valley Biotech City, numerous biopharmaceutical companies are innovating in drug development, with projects like the "Rice Blood" industrialization base expected to produce 12 million recombinant human serum albumin injections annually by 2026 [2] - The Parkinson's drug NouvNeu001 from Wuhan Ruijian Pharmaceutical Technology Co., Ltd. has achieved dual clinical approvals in China and the U.S., with a potential market launch in 2028 [2] - Wuhan's Tongji Hospital has developed the world's first myocardial rotary cutting system, showcasing the city's medical innovation on an international stage [2]
武汉成为医药新技术首发地 一批世界级创新成果陆续诞生
Chang Jiang Ri Bao·2025-06-28 00:41